Chesapeake Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03M Buy
8,290
+212
+3% +$49.4K 0.62% 48
2025
Q4
$1.67M Buy
8,078
+374
+5% +$74K 0.5% 56
2025
Q3
$1.43M Buy
7,704
+65
+0.9% +$11.1K 0.44% 60
2025
Q2
$1.17M Sell
7,639
-175
-2% -$26.9K 0.39% 65
2025
Q1
$1.3M Sell
7,814
-175
-2% -$27.4K 0.46% 60
2024
Q4
$1.16M Sell
7,989
-471
-6% -$73K 0.4% 65
2024
Q3
$1.37M Buy
8,460
+90
+1% +$14.3K 0.47% 58
2024
Q2
$1.22M Sell
8,370
-14
-0.2% -$2.08K 0.44% 61
2024
Q1
$1.33M Sell
8,384
-252
-3% -$40.1K 0.48% 59
2023
Q4
$1.35M Sell
8,636
-213
-2% -$32.7K 0.52% 56
2023
Q3
$1.38M Sell
8,849
-347
-4% -$57.3K 0.57% 53
2023
Q2
$1.52M Buy
9,196
+60
+0.7% +$9.68K 0.6% 52
2023
Q1
$1.42M Sell
9,136
-246
-3% -$39.7K 0.59% 54
2022
Q4
$1.66M Sell
9,382
-175
-2% -$30.2K 0.73% 43
2022
Q3
$1.56M Sell
9,557
-168
-2% -$28.4K 0.71% 40
2022
Q2
$1.73M Sell
9,725
-822
-8% -$146K 0.74% 37
2022
Q1
$1.87M Buy
10,547
+284
+3% +$48.3K 0.68% 37
2021
Q4
$1.75M Sell
10,263
-562
-5% -$92K 0.59% 44
2021
Q3
$1.75M Sell
10,825
-1,429
-12% -$244K 0.63% 39
2021
Q2
$2.02M Sell
12,254
-615
-5% -$102K 0.65% 36
2021
Q1
$2.12M Sell
12,869
-484
-4% -$78.3K 0.71% 31
2020
Q4
$2.1M Sell
13,353
-364
-3% -$53.7K 0.72% 28
2020
Q3
$2.04M Sell
13,717
-218
-2% -$32.3K 0.76% 27
2020
Q2
$1.96M Buy
13,935
+320
+2% +$46.6K 0.78% 26
2020
Q1
$1.78M Sell
13,615
-422
-3% -$59.9K 0.82% 27
2019
Q4
$2.05M Sell
14,037
-1,280
-8% -$174K 0.79% 28
2019
Q3
$1.98M Sell
15,317
-296
-2% -$39K 0.81% 28
2019
Q2
$2.17M Sell
15,613
-744
-5% -$103K 0.91% 22
2019
Q1
$2.29M Sell
16,357
-295
-2% -$39.5K 1% 21
2018
Q4
$2.15M Sell
16,652
-215
-1% -$30K 1.06% 20
2018
Q3
$2.33M Sell
16,867
-611
-3% -$81.2K 1.04% 22
2018
Q2
$2.12M Sell
17,478
-2,361
-12% -$295K 0.98% 24
2018
Q1
$2.54M Buy
+19,839
New +$2.68M 1.17% 17

Other funds holding JNJ

Chesapeake Wealth Management's JNJ Position: Q1 2026 in Review

Chesapeake Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.6% in Q1 2026, buying an estimated $49.4K and bringing the position to 8,290 shares worth $2.03M. The position accounts for 0.62% of the portfolio, ranked #48.

Chesapeake Wealth Management first reported a position in JNJ in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.54M in Q1 2018. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Chesapeake Wealth Management held 8,290 shares of Johnson & Johnson worth $2.03M as of Q1 2026.
  • Chesapeake Wealth Management bought 212 Johnson & Johnson shares in Q1 2026, an estimated $49.4K.
  • Johnson & Johnson made up 0.62% of Chesapeake Wealth Management's portfolio in Q1 2026, its #48 holding.
  • Chesapeake Wealth Management first reported a position in Johnson & Johnson in Q1 2018 and has held it in 33 quarters since.
  • Chesapeake Wealth Management's Johnson & Johnson position peaked at $2.54M in Q1 2018.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.